On Jan. 2, 2015, a FedEx envelope arrived with termination papers ending my career as an executive at Alcon. For me, the choice was simple: take another corporate job or bet on myself. I bet on myself. And the bet was on ear wax.
It was not an obvious choice. But every doctor and patient I talked to said the same thing — a market category that affects almost every American had been overlooked for 50 years. Tell people you make ear care products, and they don’t change the subject. They lean in, lower their voices, and tell you stories they swear they’ve never told another soul. Their kid. Their mother. The hearing they thought they were losing. Everyone has an ear wax story.
In 2015, when I started my company, eosera, in Fort Worth, the only option to treat ear wax was a four-day carbamide peroxide regimen that often failed, requiring a doctor visit and a co-pay…